Question 1

What is combined oxidative phosphorylation deficiency 36?

Accepted Answer

Combined oxidative phosphorylation deficiency 36, also known as COXPD36, is a multisystem metabolic disorder affecting energy production in cells. The condition results from pathogenic variants in the MRPS2 gene, which plays a critical role in mitochondrial protein synthesis. Affected individuals typically present in early childhood with neurological and metabolic abnormalities, including intellectual disability, global developmental delay, and increased circulating lactate. Although specific prevalence estimates are not available, the autosomal recessive inheritance pattern suggests that it is an uncommon condition.

Question 2

What are the symptoms of combined oxidative phosphorylation deficiency 36?

Accepted Answer

The clinical presentation of combined oxidative phosphorylation deficiency 36 is marked by a consistent constellation of symptoms. Neurologically, nearly all affected individuals experience intellectual disability, poor speech, and global developmental delay, underscoring the cognitive impact of the disorder. Metabolic findings such as increased circulating lactate and hypoglycemia are always present, while hypotonia further contributes to motor challenges. In addition, sensorineural hearing impairment is a characteristic feature. A number of other signs, observed in a subset of individuals, include upslanted palpebral fissures, elevated liver enzymes, hyperalaninemia, headache, exodeviation, low-set ears, premature skin wrinkling, failure to thrive, exercise intolerance, lower limb muscle weakness, and myalgia. Not all individuals experience all features, and severity varies considerably.

Question 3

What causes combined oxidative phosphorylation deficiency 36?

Accepted Answer

Combined oxidative phosphorylation deficiency 36 is caused by pathogenic variants in the MRPS2 gene. MRPS2 is responsible for encoding a protein that is essential for mitochondrial ribosome function and, consequently, for effective oxidative phosphorylation. The condition is inherited in an autosomal recessive manner, meaning that an affected individual has received one altered copy of the gene from each parent. Families are advised to seek genetic counseling to better understand the implications for current and future family planning. Associated genes include MRPS2.

Question 4

How is combined oxidative phosphorylation deficiency 36 inherited?

Accepted Answer

combined oxidative phosphorylation deficiency 36 follows an autosomal recessive inheritance pattern. This means a child must inherit a copy of the altered gene from both parents to develop the condition. Parents who each carry one copy typically do not show symptoms.

Question 5

How is combined oxidative phosphorylation deficiency 36 diagnosed?

Accepted Answer

Diagnosis of combined oxidative phosphorylation deficiency 36 involves molecular genetic testing to identify pathogenic variants in the MRPS2 gene. Clinical evaluation, including assessment of developmental history and metabolic findings such as elevated lactate levels, further supports the diagnostic process. Because many of these features can be seen in other conditions, definitive diagnosis relies on genetic testing in order to distinguish it from overlapping metabolic or neurodevelopmental disorders.

Question 6

Are there treatments for combined oxidative phosphorylation deficiency 36?

Accepted Answer

Currently, management focuses on supportive care and symptom management, with treatment plans tailored to the individual. Although there are no specific foundational therapies or approved treatments linked to this condition, a multidisciplinary approach is essential. Patients typically benefit from regular surveillance to monitor metabolic parameters and developmental progress as part of long-term care. In addition, genetic counseling is recommended to help families navigate treatment options and to plan for future care. The involvement of specialists in neurology, metabolic disorders, and developmental pediatrics can be crucial in ensuring comprehensive care.

Question 7

What complications can arise from combined oxidative phosphorylation deficiency 36?

Accepted Answer

Individuals with combined oxidative phosphorylation deficiency 36 may face various complications due to the condition's impact on energy production. Neurological issues, such as intellectual disability and developmental delays, are common and can affect daily functioning. Additionally, metabolic problems like hypoglycemia and increased lactate levels can lead to further health challenges. Regular monitoring and supportive care are essential to manage these complications.

Question 8

How does combined oxidative phosphorylation deficiency 36 affect daily life?

Accepted Answer

Living with combined oxidative phosphorylation deficiency 36 can present daily challenges, especially due to developmental delays and cognitive difficulties. Affected individuals may require assistance with speech and motor skills. Supportive therapies, such as physical and speech therapy, can help improve daily functioning. Families often need to adapt their routines to accommodate the unique needs of their loved ones.

Question 9

What is the life expectancy for someone with combined oxidative phosphorylation deficiency 36?

Accepted Answer

The life expectancy for individuals with combined oxidative phosphorylation deficiency 36 can vary widely. Many people live into adulthood, but they often face ongoing cognitive and developmental challenges. The severity of symptoms and access to specialized care can significantly influence outcomes. Families are encouraged to seek regular medical support to help manage the condition effectively.

Question 10

What specialists should be involved in the care of someone with combined oxidative phosphorylation deficiency 36?

Accepted Answer

Care for individuals with combined oxidative phosphorylation deficiency 36 often requires a team of specialists. Neurologists, metabolic disorder experts, and developmental pediatricians play crucial roles in managing the condition. These specialists can provide tailored care and monitor developmental progress. Genetic counseling is also recommended to help families understand the condition and plan for future needs.

Research Type	Count	% of Total
Laboratory research	14	42%

Kisho

combined oxidative phosphorylation deficiency 36

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Explore clinical features

Recent Publications

combined oxidative phosphorylation deficiency 36

Overview

Clinical Presentation

Genetic Landscape

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

OMIM

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is combined oxidative phosphorylation deficiency 36?

What are the symptoms of combined oxidative phosphorylation deficiency 36?

What causes combined oxidative phosphorylation deficiency 36?

How is combined oxidative phosphorylation deficiency 36 inherited?

How is combined oxidative phosphorylation deficiency 36 diagnosed?

Are there treatments for combined oxidative phosphorylation deficiency 36?

What complications can arise from combined oxidative phosphorylation deficiency 36?

How does combined oxidative phosphorylation deficiency 36 affect daily life?

What is the life expectancy for someone with combined oxidative phosphorylation deficiency 36?

What specialists should be involved in the care of someone with combined oxidative phosphorylation deficiency 36?

Explore clinical features

Recent Publications